The oral drug Xocova marks the first home-grown medication, developed by Shionogi & Co., which can be prescribed for patients with mild symptoms, suggesting a stable supply of the tablet will be ...
Ensitrelvir, known as Xocova ® in countries where it is approved, received emergency regulatory approval in Japan in 2022 and full approval in March 2024 for the treatment of COVID-19.
The name of the pill is Xocova, and its generic name is ensitrelvir ... Patients will be advised to take one tablet a day for five days if the pill is approved. Shionogi requested at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results